Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response of ChAdOx1 booster after two doses of CoronaVac in adults
TCTR20210722003Phase 2Recruiting
- Sponsor
- Health and Aging Platform
- Start
- Jul 2021
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Health and Aging Platform. Started Jul 2021; status: recruiting.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210722003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210722003.